The project is currently supported by SPARK Norway for the period 2025 – 2027.
We have previously received funding from South-Eastern Norway Regional Health Authorities and the Research Council of Norway with innovation grants. We have also received funding from Anders Jahre fond for vitenskapens fremme and Unifor-FRIMED.
We are grateful for the financial support from these organizations to reach our current stage.
We are now looking for new sponsors for our project to carry on our drug discovery efforts to make it into the preclinical in vivo stage. Contact us at Contact if you want to learn more about how you can contribute to this important drug development program.
